Premium
Anticonvulsant Profile and Teratogenicity of N ‐methyl‐tetramethylcyclopropyl Carboxamide: A New Antiepileptic Drug
Author(s) -
Isoherranen Nina,
White H. Steve,
Finnell Richard H.,
Yagen Boris,
Woodhead José H.,
Bennett Gregory D.,
Wilcox Karen S.,
Barton Matthew E.,
Bialer Meir
Publication year - 2002
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1046/j.1528-1157.2002.25801.x
Subject(s) - anticonvulsant , pentylenetetrazol , pharmacology , epilepsy , bicuculline , valproic acid , neurotoxicity , ed50 , convulsion , medicine , ethosuximide , toxicity , chemistry , endocrinology , gabaa receptor , receptor , psychiatry
Summary: Purpose: The studies presented here represent our efforts to investigate the anticonvulsant activity of N ‐methyl‐tetramethylcyclopropyl carboxamide (M‐TMCD) and its metabolite tetramethylcyclopropyl carboxamide (TMCD) in various animal (rodent) models of human epilepsy, and to evaluate their ability to induce neural tube defects (NTDs) and neurotoxicity. Methods: The anticonvulsant activity of M‐TMCD and TMCD was determined after intraperitoneal (i.p.) administration to CF#1 mice, and either oral or i.p. administration to Sprague–Dawley rats. The ability of M‐TMCD and TMCD to block electrical‐, chemical‐, or sensory‐induced seizures was examined in eight animal models of epilepsy. The plasma and brain concentrations of M‐TMCD and TMCD were determined in the CF#1 mice after i.p. administration. The induction of NTDs by M‐TMCD and TMCD was evaluated after a single i.p. administration at day 8.5 of gestation in a highly inbred mouse strain (SWV) that is susceptible to valproic acid–induced neural tube defects. Results: In mice, M‐TMCD afforded protection against maximal electroshock (MES)‐induced, pentylenetetrazol (Metrazol)‐induced, and bicuculline‐induced seizures, as well as against 6‐Hz “psychomotor” seizures and sound‐induced seizures with ED 50 values of 99, 39, 81, 51, and 10 mg/kg, respectively. In rats, M‐TMCD effectively prevented MES‐ and Metrazol‐induced seizures and secondarily generalized seizures in hippocampal kindled rats (ED 50 values of 82, 45, and 39 mg/kg, respectively). Unlike M‐TMCD, TMCD was active only against Metrazol‐induced seizures in mice and rats (ED 50 values of 57 and 52 mg/kg, respectively). Neither M‐TMCD nor TMCD was found to induce NTDs in SWV mice. Conclusions: The results obtained in this study show that M‐TMCD is a broad‐spectrum anticonvulsant drug that does not induce NTDs and support additional studies to evaluate its full therapeutic potential.